Rocca C, Pasqua T, Boukhzar L, Anouar Y, Angelone T
Data / Specifications Compound Specifications 62 H 98 N 16 O 22 Amino Acid Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Synonyms Body Protection Compound-157, Bepecin, PL 14736, PL-10 Research Applications Context / Research Interacts with multiple signaling pathways including the NO system, FAK-paxillin pathway, VEGF expression, and growth hormone receptor expression
GLP-1 use is safe and effective with many pre-existing conditions with the exception of the following: Currently pregnant Currently breastfeeding Currently being treated for cancer Active eating disorder Active gallbladder disease Active substance abuse or dependency Type 1 diabetes Bariatric surgery (within the past 18 months) Pancreatitis within the past 6 months, or a history of pancreatiitis caused by taking a GLP-1 Personal or family history of medullary thyroid cancer or MEN syndrome Personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Molecules (2014) Stable gastric pentadecapeptide BPC 157 in trials for inflam
Gently massage into the skin until the capsules fully dissolve
